A new and highly transmissible COVID-19 variant is fuelling a concerning rise in hospital admissions across the United Kingdom, prompting fresh warnings from health officials.
The strain, scientifically designated as EG.5 and colloquially nicknamed 'Eris', has rapidly become the dominant force behind new coronavirus infections. This surge is particularly alarming as it marks the first significant increase in US hospitalisations since December, a trend that UK experts fear may be mirrored here.
What We Know About the Eris Variant
According to the latest data from the US Centers for Disease Control and Prevention (CDC), Eris is now responsible for an estimated 17% of all new COVID-19 cases. Its rapid growth has seen it outcompete other circulating variants, including the previously prevalent XBB.
While there is currently no evidence to suggest the Eris variant causes more severe illness, its heightened transmissibility is the primary driver behind the uptick in cases. This has resulted in a 12.5% increase in hospitalisations in the US, with similar patterns beginning to emerge in UK data.
A Warning for the Most Vulnerable
Health professionals are issuing renewed guidance for elderly and immunocompromised individuals. The advice underscores the importance of vigilance, mask-wearing in crowded indoor spaces, and ensuring vaccinations are up to date.
The situation is being closely monitored by the UK Health Security Agency (UKHSA), which is assessing the potential impact on the NHS as we approach the autumn and winter months.
Tracking the Spread
Interesting data has emerged from major pharmacy chains like Walgreens and CVS, which conduct widespread COVID testing. Their figures provide an early indicator of community spread and have been instrumental in tracking the variant's prevalence across different regions.
This serves as a stark reminder that the virus continues to evolve and remains a active public health concern, requiring ongoing vigilance from both the public and health authorities.
